CEL-SCI Corp. | Key People and Executives
Geert R. Kersten
Chief Executive Officer, Treasurer & Director
Robert E. Watson
Director
Bruno Jean Marie Baillavoine
Independent Director
Peter R. Young
Independent Director
Geert R. Kersten
Chief Executive Officer, Treasurer & Director
Patricia B. Prichep
Secretary & Senior Vice President-Operations
Eyal Talor
Chief Scientific Officer
Daniel H. Zimmerman
Senior VP-Research & Cellular Immunology
Todd S. Burkhart
Vice President-Manufacturing & Facilities
William Jones
Vice President-Quality Assurance
Robert E. Watson
Director
Gavin de Windt
Investor Relations Contact
John Cipriano
Senior Vice President-Regulatory Affairs
Bruno Jean Marie Baillavoine
Independent Director
Peter R. Young
Independent Director
| Address |
8229 Boone Boulevard
Vienna Virginia 22182
United States
|
|
Employees
|
- |
| Website |
http://www.cel-sci.com |
| Updated |
07/08/2019 |
| CEL-SCI Corp. is a biotechnology company, which is involved in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers, and anal warts or cervical dysplasia in human immunodeficiency virus or human papillomavirus co-infected patients. |
